PTEN and cancer: Different epigenetic and genetic abnormality, mutations and functional deficiency of PTEN lead to hyperactivity of PI3K/Akt pathway in many of cancer cells.33 We evaluated the effect of PI3K and Akt inhibition on the PTEN mRNA and protein expression and phosphorylation.